Adverum Biotechnologies Stock Price and Value Analysis

Should you buy Adverum Biotechnologies stock? (NASDAQ:ADVM). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
  • This company has stable growth.
  • This company is not making money.
  • This company is less known than others.
  • This stock looks overpriced.
  • This company pays no dividend.

Inside the ADVM Numbers

ADVM Price
(Adverum Biotechnologies stock price per share)
$7.05
[?] PE Ratio versus Sector 100% lower than other Healthcare stocks
[?] PE Ratio versus Industry 100% lower than other Biotechnology stocks
[?] Free Cash Flow Jitter 16%

Is Adverum Biotechnologies Stock on Sale?

Based on our analysis, we believe that you should not buy Adverum Biotechnologies right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy ADVM Stock?

Does Adverum Biotechnologies have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.